Characteristics of Lipoprotein Peak x Eluted from a Column with the Eluent of High-magnesium Ion Concentration in Lipoprotein Analysis Using the Cation-exchange Chromatography

The new lipoprotein analysis method using a cation-exchange chromatography, which contains a sulfopropyl-ligand column and two magnesium ion-containing eluents was previously reported. This method can separate serum lipoproteins on the column gel with a magnesium ion concentration gradient and high-density lipoprotein (HDL), low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL) and an unspecified lipoprotein peak are eluted in order from the column. We have now characterized the unspecified lipoproteins, designated peak x, which is last eluted from the column with the eluent of high-magnesium ion concentration. The peak x was small size chylomicron fraction with a part of VLDL. Furthermore, the cholesterol values in the peak x were significantly correlated with remnant-like particle (RLP)-cholesterol values. The peak x separated from a hyperlipidemic patient included apolipoprotein B-100, B-48, E, A-1 and Cs (C-I, C-II, C-III) and its composition of free cholesterol, cholesteryl esters, triglyceride (TG) and phospholipids in total lipids were 6, 15, 66 and 13%, respectively. These results suggest that a major part of the lipoprotein peak X may be composed of remnants of chylomicron and VLDL, but it remains to be elucidated.

[1]  N. Tada,et al.  Measurement of cholesterol of major serum lipoprotein classes by anion-exchange HPLC with perchlorate ion-containing eluent Published, JLR Papers in Press, May 1, 2003. DOI 10.1194/jlr.D300003-JLR200 , 2003, Journal of Lipid Research.

[2]  A. Cooper,et al.  Induction of atherosclerosis by human chylomicron remnants: a hypothesis. , 2003, Journal of atherosclerosis and thrombosis.

[3]  D. Saito,et al.  Risk factors indicating recurrent myocardial infarction after recovery from acute myocardial infarction. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[4]  N. Tada,et al.  Analysis method for lipoproteins by high-performance liquid chromatography with sulfopropyl-ligand column and magnesium ion-containing eluents. , 2002, Analytical biochemistry.

[5]  Mitsuyo Okazaki,et al.  A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. , 2002, Journal of lipid research.

[6]  R. Krauss,et al.  Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma. , 2002, Journal of lipid research.

[7]  J. Mcconnell,et al.  Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. , 2001, Clinical chemistry.

[8]  N. Tajima,et al.  Lipoprotein analysis using agarose gel electrophoresis and differential staining of lipids. , 2000, Journal of atherosclerosis and thrombosis.

[9]  S. Devaraj,et al.  Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease. , 2000, Clinical chemistry.

[10]  H. Hodis Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. , 1999, Circulation.

[11]  H Yasue,et al.  Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. , 1999, Circulation.

[12]  R. Havel,et al.  Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma. , 1998, Clinical chemistry.

[13]  R. Heine,et al.  Measurement of LDL particle size in whole plasma and serum by high performance gel-filtration chromatography using a fluorescent lipid probe. , 1998, Clinical chemistry.

[14]  J. Haginaka,et al.  Anion-exchange high-performance liquid chromatographic assay of plasma lipoproteins. , 1995, Analytical biochemistry.

[15]  S. Grundy,et al.  National Cholesterol Education Program, second report of the Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. , 1995 .

[16]  D. Jacobs,et al.  Pulmonary function and cardiovascular risk factor relationships in black and in white young men and women. The CARDIA Study. , 1991, Chest.

[17]  E. R. Brumbaugh A Look Back and a Look Ahead , 1983 .

[18]  D. Steinberg Lipoproteins and atherosclerosis. A look back and a look ahead. , 1983, Arteriosclerosis.

[19]  S. Sabesin,et al.  Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery. , 1982, Journal of lipid research.

[20]  M. Kameyama,et al.  Lipoprotein Abnormalities in the Pathogenesis of Cerebral Infarction and Transient Ischemic Attack , 1981, Stroke.

[21]  J. Kane,et al.  Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Schaefer,et al.  Lipoprotein apoprotein metabolism. , 1978, Journal of lipid research.

[23]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[24]  B. Bloom Lipoproteins and atherosclerosis. , 1952, Arizona medicine.

[25]  J. Gofman,et al.  Lipoproteins and atherosclerosis. , 1951, Journal of gerontology.

[26]  V. Schumaker,et al.  Sequential flotation ultracentrifugation. , 1986, Methods in enzymology.